{"altmetric_id":564059,"counts":{"readers":{"mendeley":232,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["AnnemarieVtW"],"posts_count":1}},"selected_quotes":["Production platforms biotherapeutic glycoproteins\/Occurrence, impact & challenges non-human sialylation #biobetter mAbs"],"citation":{"altmetric_jid":"4f6fa9193cf058f61000d2a8","authors":["Darius Ghaderi","Mai Zhang","Nancy Hurtado-Ziola","Ajit Varki"],"doi":"10.5661\/bger-28-147","endpage":"175","first_seen_on":"2012-01-18T09:05:03+00:00","issns":["02648725","20465556"],"issue":"1","journal":"Biotechnology genetic engineering reviews","last_mentioned_on":1326876906,"links":["http:\/\/www.ingentaconnect.com\/content\/nupress\/bger\/2012\/00000028\/00000001\/art00010"],"pubdate":"2012-01-05T00:00:00+00:00","publisher_subjects":[{"name":"Biological Sciences","scheme":"era"},{"name":"Engineering","scheme":"era"},{"name":"Technology","scheme":"era"}],"scopus_subjects":["Life Sciences","Chemical Engineering","Physical Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"147","title":"Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation","type":"article","volume":"28","mendeley_url":"http:\/\/www.mendeley.com\/research\/production-platforms-biotherapeutic-glycoproteins-occurrence-impact-challenges-nonhuman-sialylation"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4505992,"mean":5.1115236646191,"rank":3111297,"this_scored_higher_than_pct":22,"this_scored_higher_than":1007720,"rank_type":"exact","sample_size":4505992,"percentile":22},"similar_age_3m":{"total_number_of_other_articles":235864,"mean":4.2392578149182,"rank":148797,"this_scored_higher_than_pct":24,"this_scored_higher_than":58338,"rank_type":"exact","sample_size":235864,"percentile":24},"this_journal":{"total_number_of_other_articles":25,"mean":1.3385,"rank":17,"this_scored_higher_than_pct":24,"this_scored_higher_than":6,"rank_type":"exact","sample_size":25,"percentile":24},"similar_age_this_journal_3m":{"total_number_of_other_articles":2,"mean":0.25,"rank":1,"this_scored_higher_than_pct":50,"this_scored_higher_than":1,"rank_type":"exact","sample_size":2,"percentile":50}}},"demographics":{"poster_types":{"researcher":1},"users":{"twitter":{"cohorts":{"Scientists":1}},"mendeley":{"by_status":{"Unspecified":3,"Professor > Associate Professor":7,"Researcher":69,"Student  > Doctoral Student":11,"Student  > Ph. D. Student":57,"Student  > Postgraduate":4,"Student  > Master":41,"Other":12,"Student  > Bachelor":23,"Lecturer":2,"Professor":3},"by_discipline":{"Medicine and Dentistry":12,"Unspecified":5,"Pharmacology, Toxicology and Pharmaceutical Science":4,"Chemical Engineering":2,"Design":1,"Engineering":19,"Chemistry":21,"Immunology and Microbiology":5,"Agricultural and Biological Sciences":129,"Business, Management and Accounting":1,"Linguistics":1,"Biochemistry, Genetics and Molecular Biology":31,"Veterinary Science and Veterinary Medicine":1}}},"geo":{"twitter":{"NL":1},"mendeley":{"AR":2,"HU":1,"US":3,"GB":2,"CH":1,"PT":3,"CA":2,"AT":2,"BE":1,"BR":1,"DK":1,"MX":1,"AU":1,"DE":3}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/AnnemarieVtW\/status\/159559425915502593","citation_ids":[564059],"posted_on":"2012-01-18T08:55:06+00:00","author":{"name":"A. Vroom - Ten Wolde","url":"http:\/\/nl.linkedin.com\/in\/annemarievroomtenwolde","image":"https:\/\/pbs.twimg.com\/profile_images\/1118347634\/Annemarie-photo_normal.png","description":"PhD Organic Chemistry; Science Writer #Biotech\/#Pharma #biologics #biosimilars #antibody #mAbs #ADCs #bispecifics #biobetters #health #chemistry","id_on_source":"AnnemarieVtW","tweeter_id":"185567498","geo":{"lt":52.5,"ln":5.75,"country":"NL"},"followers":2239},"tweet_id":"159559425915502593"}]}}